|
Volume
21 Number 4
April 2019
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
21, Year 2019 >
Number 4,
April
|
|
Contents
|
▼
|
|
Central
nervous system tumors
|
|
Gliomas
|
|
○ High-grade
gliomas
|
|
○ Low-grade
gliomas
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
|
○
Glioblastoma
|
|
○
Diffuse
Midline Glioma
|
|
Ependymal
tumors
|
|
○
Ependymoma
|
|
Embryonal
tumors
|
|
○
Medulloblastoma
|
|
○
Atypical
theratoid/rhabdoid tumor
|
|
Lymphomas
|
|
|
|
|
|
Liu
XF, Du X, Zhang XT, Yang M, Han YM, Lin XY.
Pleomorphic
xanthoastrocytoma inside lateral ventricle: a rare case report and
literature review.
Int
J Clin Exp Pathol.
2019
Apr 1;12(4):1118-1123. _
|
|
|
Central
nervous system tumors
|
▲
|
|
Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR,
Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce
JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM,
Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson
JH, Taylor MD, Workman P, Gilbertson RJ.
Challenges to
curing primary brain tumours.
Nat
Rev Clin Oncol. 2019 Feb 7. doi:
10.1038/s41571-019-0177-5. _
|
|
|
|
Chi
AS et
al, PDQ Adult Treatment Editorial Board.
Adult
Central Nervous System Tumors Treatment (PDQ®): Patient
Version.
PDQ
Cancer Inf Summ [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Feb 6. _
|
|
|
|
Chukwueke UN, Wen PY.
Use of the Response Assessment in
Neuro-Oncology (RANO) criteria in clinical trials and clinical
practice.
CNS
Oncol. 2019 Feb 26. 2019;8(1):CNS28. doi:
10.2217/cns-2018-0007. _
|
|
|
|
Janss AJ, Mazewski C, Patterson B.
Guidelines for
Treatment and Monitoring of Adult Survivors of Pediatric Brain
Tumors.
Curr
Treat Options Oncol. 2019 Feb 9;20(1):10. doi:
10.1007/s11864-019-0602-0. _
|
|
|
|
Ruff MW, Uhm JH, Benarroch EE.
Neuro-oncology:
Implications of the molecular era.
Neurology.
2019 Feb 13. 2019;92(12):568-574. doi:
10.1212/WNL.0000000000007126. _
|
|
|
Gliomas
|
▲
|
|
Daniel P, Sabri S, Chaddad A, Meehan B, Jean-Claude B, Rak J,
Abdulkarim BS.
Temozolomide Induced Hypermutation in
Glioma: Evolutionary Mechanisms and Therapeutic Opportunities.
Front
Oncol. 2019 Feb 4;9:41. doi:
10.3389/fonc.2019.00041. _
|
|
|
|
Miklja Z, Pasternak A, Stallard S, Nicolaides T, Kline-Nunnally C,
Cole B, Beroukhim R, Bandopadhayay P, Chi S, Ramkissoon SH, Mullan
B, Bruzek AK, Gauthier A, Garcia T, Atchison C, Marini B, Fouladi
M, Parsons DW, Leary S, Mueller S, Ligon KL, Koschmann C.
Molecular profiling and targeted therapy in pediatric
gliomas: review and consensus recommendations.
Neuro
Oncol. 2019 Feb 26. doi: 10.1093/neuonc/noz022.
_
|
|
|
High-grade
gliomas
|
|
|
Pierscianek D, Ahmadipour Y, Oppong MD, Rauschenbach L, Kebir S,
Glas M, Sure U, Jabbarli R.
Blood-Based Biomarkers in
High Grade Gliomas: a Systematic Review.
Mol
Neurobiol. 2019 Feb 4. doi:
10.1007/s12035-019-1509-2. _
|
|
|
Low-grade
gliomas
|
|
⋆
|
Burak Atci I, Yilmaz H, Samanci MY.
The
top 50 most-cited articles on low-grade glioma: a bibliometric
analysis.
Br J
Neurosurg. 2019
Apr;33(2):171-175⍈.
doi: 10.1080/02688697.2018.1549314⍈.
Epub
2019 Jan 12. PMID:
30636460⍈.
Bibliometric analysis. ⍈
|
|
|
|
Schiff D, van den Bent M, Vogelbaum MA, Wick W, Miller CR,
Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T,
Wen PY.
Recent Developments and Future Directions in
Adult Lower-Grade Gliomas: Society for Neuro-Oncology (SNO) and
European Association of Neuro-Oncology (EANO) Consensus.
Neuro
Oncol. 2019 Feb 8. doi: 10.1093/neuonc/noz033.
_
|
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
▲
|
|
|
Glioblastoma
|
|
|
Baratta MG.
Glioblastoma is 'hot' for personalized
vaccines.
Nat Rev Cancer. 2019 Jan 31. 2019;19(3):129.
doi: 10.1038/s41568-019-0118-8. _
Article
review referring to:
Keskin
DB et al., Neoantigen vaccine generates intratumoral T cell
responses in phase Ib glioblastoma trial. Nature.
2018 Dec 19. 2019;565(7738):234-239. doi:
10.1038/s41586-018-0792-9.
_
Hilf
N et al., Actively personalized vaccination trial for newly
diagnosed glioblastoma.
Nature.
2018
Dec 19. 2019;565(7738):240-245. doi: 10.1038/s41586-018-0810-y.
_
─ Erratum
in:
Nature.
2019
Feb 7. 2019;566(7745):E13.
doi:
10.1038/s41586-019-0959-z.
_
|
|
|
|
Gupta R, Sharma D.
Evolution of Magnetic Hyperthermia for
Glioblastoma Multiforme Therapy.
ACS
Chem Neurosci. 2019 Feb 4. 2019;10(3):1157-1172.
doi: 10.1021/acschemneuro.8b00652. _
|
|
|
|
Killock D.
Lomustine-temozolomide combination efficacious
in newly diagnosed glioblastoma.
Nat
Rev Clin Oncol. 2019 Feb 26. doi:
10.1038/s41571-019-0192-6. _
Article
review referring to:
Herrlinger U, et al., Lomustine-temozolomide combination therapy
versus standard temozolomide therapy in patients with newly
diagnosed glioblastoma with methylated MGMT promoter
(CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet.
2019 Feb 16;393(10172):678-688. doi:
10.1016/S0140-6736(18)31791-4.
_
|
|
|
|
Levin VA.
How far will the Voyager®
take us?
CNS
Oncol. 2019 Feb 15. 2019;8(1):CNS26. doi:
10.2217/cns-2018-0019. _
Editorial
referring to:
Cobbs
C et al., An early feasibility study of the Nativis Voyager device
in patients with recurrent glioblastoma: first cohort in US. CNS
Oncol.
2018 Dec 14. 2019;8(1):CNS30. doi: 10.2217/cns-2018-0013.
_
Murphy
M et al.,A feasibility study of the Nativis Voyager device in
patients with recurrent glioblastoma in Australia. CNS
Oncol.
2019 Feb 7. 2019;8(1):CNS31. doi: 10.2217/cns-2018-0017.
_
|
|
|
|
Loo HK, Mathen P, Lee J, Camphausen K.
Circulating
biomarkers for high-grade glioma.
Biomark
Med. 2019 Feb 26. 2019;13(3):161-165. doi:
10.2217/bmm-2018-0463. _
|
|
|
|
McGranahan T, Therkelsen KE, Ahmad S, Nagpal S.
Current
State of Immunotherapy for Treatment of Glioblastoma.
Curr
Treat Options Oncol. 2019 Feb 21;20(3):24. doi:
10.1007/s11864-019-0619-4. _
|
|
|
|
[No
authors listed]
Progress
in the fight against brain cancer.
Nature.
2019 Jan 9;565(7738):134. doi: 10.1038/d41586-019-00077-1.
_
Editorial
referring to:
Keskin
DB et al., Neoantigen vaccine generates intratumoral T cell
responses in phase Ib glioblastoma trial. Nature.
2018 Dec 19. 2019;565(7738):234-239. doi:
10.1038/s41586-018-0792-9.
_
Hilf
N et al., Actively personalized vaccination trial for newly
diagnosed glioblastoma.
Nature.
2018
Dec 19. 2019;565(7738):240-245. doi: 10.1038/s41586-018-0810-y.
_
─ Erratum
in:
Nature.
2019
Feb 7. 2019;566(7745):E13.
doi:
10.1038/s41586-019-0959-z.
_
Zaidi
N et al., Immune
cells track hard-to-target brain tumours.
Nature.
2018 Dec 19. 2019;565(7738):170-171. doi:
10.1038/d41586-018-07728-9. _
Article
review in turn referring to:
Keskin
DB et al., Neoantigen vaccine generates intratumoral T cell
responses in phase Ib glioblastoma trial. Nature.
2018 Dec 19. 2019;565(7738):234-239. doi:
10.1038/s41586-018-0792-9.
_
Hilf
N et al., Actively personalized vaccination trial for newly
diagnosed glioblastoma.
Nature.
2018
Dec 19. 2019;565(7738):240-245. doi: 10.1038/s41586-018-0810-y.
_
─ Erratum
in:
Nature.
2019
Feb 7. 2019;566(7745):E13.
doi:
10.1038/s41586-019-0959-z.
_
|
|
|
|
Piper K, Foster H, Gabel B, Nabors B, Cobbs C.
Glioblastoma
Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series
and Literature Review.
Front
Oncol. 2019 Jan 22;9:8. doi:
10.3389/fonc.2019.00008. _
|
|
|
|
Pirmoradi L, Seyfizadeh N, Ghavami S, Zeki AA, Shojaei S.
Targeting cholesterol metabolism in glioblastoma: a new
therapeutic approach in cancer therapy.
J
Investig Med. 2019 Feb 14. 2019;67(4):715-719. doi:
10.1136/jim-2018-000962. _
|
|
|
|
Shepherd STC, Litchfield K, Turajlic S.
Searching for the
needle in the haystack: deconvoluting the evolutionary dynamics of
residual disease in human glioblastoma.
Ann
Oncol. 2019 Feb 7. doi: 10.1093/annonc/mdz042.
_
Editorial
referring to: Spiteri I et al., Evolutionary dynamics of residual
disease in human glioblastoma. Ann
Oncol.
2018 Nov 19. doi: 10.1093/annonc/mdy506.
_
|
|
|
Diffuse
midline gliomas
|
|
|
Buus-Gehrig C, Lehrnbecher T, Porto L, Becker M, Freiman T,
Mittelbronn M, Bochennek K.
Pontine tumor in a neonate:
case report and analysis of the current literature.
J
Neurosurg Pediatr. 2019 Feb 15:1-7. doi:
10.3171/2018.10.PEDS18215; _
|
|
|
|
Himes BT, Zhang L, Daniels DJ.
Treatment Strategies in
Diffuse Midline Gliomas With the H3K27M Mutation: The Role of
Convection-Enhanced Delivery in Overcoming Anatomic Challenges.
Front
Oncol. 2019 Feb 8. 2019;9:31. doi:
10.3389/fonc.2019.00031. _
|
|
|
|
Mora J.
Editorial: Proceedings From the 4th Memorial
Alicia Pueyo Workshop: "Moving Towards a Cure for Diffuse
Intrinsic Pontine Glioma".
Front
Oncol. 2019 Jan 31. 2019;9:42. doi:
10.3389/fonc.2019.00042. _
|
|
|
|
Traylor JI, Kuo JS.
"Liquid Biopsy" of
Circulating Tumor DNA Characterizes Treatment Response in
Pediatric Patients Diffuse Midline Glioma.
Neurosurgery.
2019 Feb 22. pii: nyz029. doi: 10.1093/neuros/nyz029.
_
Article
review referring to: Panditharatna E, et al., Clinically Relevant
and Minimally Invasive Tumor Surveillance of Pediatric Diffuse
Midline Gliomas Using Patient-Derived Liquid Biopsy. Clin
Cancer Res.
2018 Oct 15. 2018;24(23):5850-5859. doi:
10.1158/1078-0432.CCR-18-1345.
_
|
|
|
Ependymal
tumors
|
▲
|
|
|
Ependymoma
|
|
|
Cohen
KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ
[Internet].
Bethesda (MD): National Cancer Institute (US); 2002-2019 Jan 29.
_
|
|
|
Embryonal
tumors
|
▲
|
|
|
Medulloblastoma
|
|
.
|
Fults DW, Taylor MD, Garzia L.
Leptomeningeal
dissemination: a sinister pattern of medulloblastoma growth.
J
Neurosurg Pediatr. 2019 Feb 15:1-9. doi:
10.3171/2018.11.PEDS18506; _
|
|
|
|
Northcott PA, Robinson
GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S,
Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM.
Medulloblastoma.
Nat
Rev Dis Primers. 2019 Feb 14;5(1):11. doi:
10.1038/s41572-019-0063-6. _
─ PrimeView
_
|
|
|
Atypical
theratoid/rhabdoid tumor
|
|
|
Cohen
KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood
Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment
(PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ
[Internet].
Bethesda (MD): National Cancer Institute (US); 2002-2019 Jan 28. _
|
|
|
Lymphomas
|
▲
|
|
Siegal T, Bairey O.
Primary CNS Lymphoma in the Elderly:
The Challenge.
Acta
Haematol. 2019 Feb 15;141(3):138-145. doi:
10.1159/000495284. _
|
|
|
bottom
|
▲
|
|
|
